Skip to main content

Table 1 Clinical characteristics of the overall population at baseline and follow-up

From: Role of serial cardiac 18F-FDG PET-MRI in Anderson–Fabry disease: a pilot study

  Baseline study Follow-up study
Patients (n) 16 13
Age (years) 45 ± 13 50 ± 14
Male gender, n (%) 8 (50) 6 (62)
Weight (kg) 68 ± 12 70 ± 11
Hypertension, n (%) 5 (31) 5 (38)
Smoking, n (%) 1 (6) 1 (8)
Classic Anderson–Fabry disease, n (%) 13 (81) 10 (77)
Late onset Anderson–Fabry disease, n (%) 3 (19) 3 (23)
Enzyme replacement therapy, n (%) 6 (37) 12 (92)
Left ventricular mass (g) 58 ± 23 54 ± 8
Left ventricular end-diastolic volume (mL) 77 ± 19 76 ± 7
Left ventricular end-systolic volume (mL) 26 ± 10 29 ± 2
Left ventricular ejection fraction (%) 67 ± 7 63 ± 7
  1. Values are expressed as mean value ± standard deviation or as number (percentage) of subjects